A research team led by scientists at UC Riverside and UCLA has engineered novel nanoparticles to serve as "molecular traps" to target SARS-CoV-2, the virus that spreads COVID-19. The traps bind to SARS-CoV-2 and prevent it ...
Jan 31, 2022
0
64
Chronic obstructive pulmonary disease—COPD for short—is one of the most common diseases of the lung. It affects almost 300 million people worldwide, of which about three million die every year. A collective term for chronic ...
Jan 14, 2022
0
19
Lungs are exposed to microorganisms such as bacteria and viruses. Thanks to immune cells in the lungs, so-called macrophages, we are protected from most infections at an early age. In a new study published in the Journal ...
Jan 12, 2022
0
31
Researchers at the Garvan Institute of Medical Research have revealed that a common osteoporosis treatment boosts immune cells in the lung that form one of the first lines of defense against pathogens.
Jan 6, 2022
0
55
New Cleveland Clinic research has found that drugs originally designed to help treat Alzheimer's disease may hold promise for glioblastoma, the most common and lethal type of primary brain tumor. The findings were published ...
Nov 23, 2021
0
60
According to the Centers for Disease Control and Prevention, heart failure affects more than 6 million Americans and is the main cause of death for one in eight patients.
Nov 12, 2021
0
41
Macrophages are key cells of the immune system with many important beneficial functions, but they can also exacerbate many common diseases.
Nov 2, 2021
0
72
Scientists from the Trinity Biomedical Sciences Institute (TBSI) have discovered two new ways to block inflammatory macrophages—front-line cells in our immune system that cause complications in a suite of diseases, including ...
Oct 19, 2021
0
14
Inflammation is part of the process that weakens the heart, leading to heart failure. In response to pressure overload such as hypertension, monocytes (a type of white blood cell) enter the heart and become inflammatory macrophages.
Oct 14, 2021
0
11
A study led by researchers at the University of Chicago and Indiana University has determined that a protein called elF5A is necessary for driving inflammation in macrophage cells in obesity. Blocking DHPS, the enzyme that ...
Sep 7, 2021
0
78
